Fig. 6

Optimization of experimental conditions for remdesivir and levodropropizine with regard to diluting solvent (a), buffer type (b), and buffer volume (c)
Optimization of experimental conditions for remdesivir and levodropropizine with regard to diluting solvent (a), buffer type (b), and buffer volume (c)